Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA vs AARTI PHARMALABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAL PHARMA AARTI PHARMALABS BAL PHARMA/
AARTI PHARMALABS
 
P/E (TTM) x 28.4 24.5 115.6% View Chart
P/BV x 3.1 3.2 98.7% View Chart
Dividend Yield % 0.9 0.5 180.6%  

Financials

 BAL PHARMA   AARTI PHARMALABS
EQUITY SHARE DATA
    BAL PHARMA
Mar-24
AARTI PHARMALABS
Mar-24
BAL PHARMA/
AARTI PHARMALABS
5-Yr Chart
Click to enlarge
High Rs132595 22.2%   
Low Rs67272 24.8%   
Sales per share (Unadj.) Rs214.7204.4 105.0%  
Earnings per share (Unadj.) Rs4.723.9 19.7%  
Cash flow per share (Unadj.) Rs11.132.0 34.6%  
Dividends per share (Unadj.) Rs1.203.00 40.0%  
Avg Dividend yield %1.20.7 173.6%  
Book value per share (Unadj.) Rs43.9193.8 22.6%  
Shares outstanding (eoy) m15.8090.63 17.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.52.1 21.9%   
Avg P/E ratio x21.218.1 117.0%  
P/CF ratio (eoy) x9.013.5 66.5%  
Price / Book Value ratio x2.32.2 101.9%  
Dividend payout %25.512.5 203.2%   
Avg Mkt Cap Rs m1,57839,277 4.0%   
No. of employees `000NANA-   
Total wages/salary Rs m6041,280 47.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,39218,526 18.3%  
Other income Rs m2849 58.2%   
Total revenues Rs m3,42118,575 18.4%   
Gross profit Rs m3173,860 8.2%  
Depreciation Rs m101732 13.8%   
Interest Rs m154172 89.7%   
Profit before tax Rs m903,005 3.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m16836 1.9%   
Profit after tax Rs m742,169 3.4%  
Gross profit margin %9.320.8 44.9%  
Effective tax rate %17.727.8 63.6%   
Net profit margin %2.211.7 18.7%  
BALANCE SHEET DATA
Current assets Rs m2,34113,456 17.4%   
Current liabilities Rs m2,0306,944 29.2%   
Net working cap to sales %9.235.2 26.1%  
Current ratio x1.21.9 59.5%  
Inventory Days Days1327 49.7%  
Debtors Days Days1,0721,023 104.8%  
Net fixed assets Rs m83012,365 6.7%   
Share capital Rs m158453 34.9%   
"Free" reserves Rs m53517,115 3.1%   
Net worth Rs m69317,568 3.9%   
Long term debt Rs m3630 93,202.6%   
Total assets Rs m3,17125,821 12.3%  
Interest coverage x1.618.5 8.6%   
Debt to equity ratio x0.50 2,362,964.9%  
Sales to assets ratio x1.10.7 149.1%   
Return on assets %7.29.1 79.6%  
Return on equity %10.712.3 87.0%  
Return on capital %23.218.1 128.2%  
Exports to sales %57.540.0 143.5%   
Imports to sales %18.814.0 134.8%   
Exports (fob) Rs m1,9507,419 26.3%   
Imports (cif) Rs m6382,585 24.7%   
Fx inflow Rs m1,9507,419 26.3%   
Fx outflow Rs m6912,585 26.7%   
Net fx Rs m1,2594,834 26.0%   
CASH FLOW
From Operations Rs m2282,164 10.5%  
From Investments Rs m-189-2,146 8.8%  
From Financial Activity Rs m-1297 -12.4%  
Net Cashflow Rs m27115 23.5%  

Share Holding

Indian Promoters % 46.7 45.9 101.8%  
Foreign collaborators % 4.1 0.2 2,423.5%  
Indian inst/Mut Fund % 0.1 18.7 0.7%  
FIIs % 0.1 7.4 1.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.1 53.9 91.2%  
Shareholders   16,007 185,436 8.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAL PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on BAL PHARMA vs AARTI PHARMALABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BAL PHARMA vs AARTI PHARMALABS Share Price Performance

Period BAL PHARMA AARTI PHARMALABS S&P BSE HEALTHCARE
1-Day 4.43% -2.64% 0.11%
1-Month 6.91% 2.76% -3.22%
1-Year 27.67% 55.42% 42.65%
3-Year CAGR 13.68% 17.88% 19.86%
5-Year CAGR 27.38% 10.37% 25.90%

* Compound Annual Growth Rate

Here are more details on the BAL PHARMA share price and the AARTI PHARMALABS share price.

Moving on to shareholding structures...

The promoters of BAL PHARMA hold a 50.9% stake in the company. In case of AARTI PHARMALABS the stake stands at 46.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BAL PHARMA and the shareholding pattern of AARTI PHARMALABS.

Finally, a word on dividends...

In the most recent financial year, BAL PHARMA paid a dividend of Rs 1.2 per share. This amounted to a Dividend Payout ratio of 25.5%.

AARTI PHARMALABS paid Rs 3.0, and its dividend payout ratio stood at 12.5%.

You may visit here to review the dividend history of BAL PHARMA, and the dividend history of AARTI PHARMALABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.